JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258907

Human HPCAL1 (VILIP3) knockout HeLa cell lysate

Human HPCAL1 (VILIP3) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

HPCAL1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 14 bp deletion in exon 3.

別名を表示する

VILIP-3, Hippocalcin-like protein 1, Calcium-binding protein BDR-1, BDR1, HLP2, Visinin-like protein 3, HPCAL1

1 Images
Sanger Sequencing - Human HPCAL1 (VILIP3) knockout HeLa cell lysate (AB258907)
  • Sanger seq

Unknown

Sanger Sequencing - Human HPCAL1 (VILIP3) knockout HeLa cell lysate (AB258907)

Homozygous : 14 bp deletion in exon 3

Key facts

細胞タイプ

HeLa

生物種

Human

組織

Cervix

ノックアウト検証方法

Sanger Sequencing

ノックアウト変異

Knockout achieved by using CRISPR/Cas9, Homozygous: 14 bp deletion in exon 3.

疾病

Adenocarcinoma

製品の詳細

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

製品内容

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258907-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258907-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human HPCAL1 knockout HeLa cell lysate", "number":"AB258907-CMP01", "productcode":"" } ] } } }

出荷温度及び保存条件

遺伝子名
HPCAL1
遺伝子編集のタイプ
Knockout
遺伝子編集の方法
CRISPR technology
ノックアウト検証方法
Sanger Sequencing
接合型
Homozygous
出荷温度
Ambient - Can Ship with Ice
短期保存温度
-20°C
長期保存温度
-20°C

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

VILIP3 also known as Visinin-like protein 3 is a member of the neuronal calcium sensor (NCS) family. This protein holds a mass of approximately 22 kDa and plays a critical role in calcium signaling. VILIP3 is expressed in the brain and has been found in different neuronal tissues. It acts mechanically by binding calcium ions and undergoing a conformational change which allows it to interact with other intracellular targets. This binding modulates various cellular processes essential for the proper functioning of neurons.
Biological function summary

VILIP3 influences neuronal signaling pathways and synaptic plasticity. This protein does not operate as part of a large complex but interacts with specific target proteins. It aids in regulating the function of cyclic nucleotide signaling impacting cellular processes like neuronal communication and response to stimuli. VILIP3 may also play a role in sensory perception through its influence on calcium-dependent pathways.

Pathways

This neuronally expressed protein directly influences the cyclic adenosine monophosphate (cAMP) signaling pathway. This pathway is vital for neurotransmission and memory formation processes. VILIP3 interacts with proteins such as adenylate cyclases which are key enzymes in the cAMP pathway. It helps modulate the activity of these enzymes affecting the production of cAMP and influencing signal transduction in neurons.

VILIP3 has a connection to neurodegenerative disorders such as Alzheimer's disease and certain forms of epilepsy. In Alzheimer's VILIP3 may interact with proteins like amyloid-beta precursor protein contributing to the disease pathology. Additionally disruptions in calcium signaling involving VILIP3 may relate to epileptic activity where it connects with proteins in calcium pathways that influence neuronal excitability and network stability. Researchers are continuing to investigate these relationships to better understand and address these conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

製品プロトコール

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com